Just In
- 11 min ago What Your Tongue Reveals About Your Health: Wellness And Warning Signs You Need To Know
- 42 min ago How Can You Protect Yourself From Extreme Heat? Dos And Don’ts To Follow
- 5 hrs ago Daily Horoscope, 23 April 2024: Cancer Will Have A Good Day In Terms Of Finances
- 10 hrs ago Hanuman Jayanti 2024: Hanuman Chalisa Lyrics With Meaning, When And How Many Times To Recite It
Don't Miss
- News Watch: 2 Malaysian Military Helicopters Crash Mid-Air, 10 Killed
- Automobiles Maruti Suzuki Ertiga Continues To Lead the MPV Market Despite Long Waits
- Movies Love Sex Aur Dhokha 2 Box Office Collection Day 4: LSD 2 Scores LOWEST On 1st Monday; Struggles To Cross 1 Cr
- Finance US Hedge Fund Jane Street & Millenium Management's $1 Bn Trade Puts Spotlight On Indian Options Market
- Education Telangana Inter Results 2024: How to Check Results Online at tsbie.cgg.gov.in?
- Sports CSK vs LSG IPL 2024: Four Batters Who Can Score Most Runs in Match 39
- Technology Moto G64 5G Goes on Sale in India at 12 noon Today via Flipkart: Check Price, Specs, Offers
- Travel Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Serum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
Serum Institute of India has urged the Union government to include Covovax in the National COVID-19 Vaccination programme for inoculating those aged 12 years and above, official sources said on Tuesday, March 15. The Pune-based SII said it wants to provide Covovax to private hospitals at Rs 900 per dose plus GST and is also waiting for directions to supply the vaccine to the Centre but has not mentioned the price.
India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain conditions on March 9 and for 18 years and above on December 28.
In a letter to Health Secretary Rajesh Bhushan, Director, Government and Regulatory Affairs at SII Prakash Kumar Singh said private companies, educational institutes, social organizations, Central government organizations and Public sector undertakings are making requests for Covovax to inoculate their staffers, families and children, an official source said.
Singh is also learnt to have stated that the Pune-based firm has decided the price of Covovax for supply to private hospitals at the rate of Rs 900 plus GST per dose.
"Also, we are waiting for your kind direction for supplies of our Covovax vaccine to the Government of India," Singh mentioned in his letter.
"Under the visionary leadership of our CEO Adar C Poonawalla, we have developed, manufactured and obtained emergency use authorization from our national regulatory authority for one more world-class COVID-19 vaccine Covovax for 18 years and above on December 28, and for children in the age group of 12 to 17 years on March 9, 2022," an official source quoted Singh as having said in the letter.
He has also requested necessary changes on the CoWin portal for the addition of the Covovax vaccine to inoculate people.
The COVID vaccination for children in the age group of 12 to 14 years will begin from Wednesday. The vaccine to be given to this age group would be Corbevax manufactured by Hyderabad-based Biological E. Limited.
- wellnessGovt Panel Recommends Emergency Approval For SII's Covovax For 7-11 Year Olds
- kidsDCGI Panel To Review On Friday SII Applications For Covovax’s Use Among Kids Aged 2-7 Yrs, 7-11 Yrs
- basicsNovavax's Covid-19 Vaccine Covovax Gets Emergency Use Authorisation For 12-17 Age Group In India
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- wellnessGovt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults
- wellnessSII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults
- healthIndia-US Healthcare Collaboration In Spotlight As India Approves Two More Covid-19 Vaccines
- healthCovovax Better Booster For Covishield-Vaccinated People: Dr Shahid Jameel, Virologist
- wellnessCovovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India
- healthCovovax Approval To Strengthen Immunisation Efforts In India, Lower & Middle-Income Countries: SII
- healthPanel Recommends EUA For Covid-19 Vaccines Covovax, Corbevax And Anti-Covid Pill Molnupiravir
- healthSerum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use